Bank of Montreal’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-107,700
| Closed | -$238K | – | 3567 |
|
|
2024
Q1 | $238K | Buy |
107,700
+36,400
| +51% | +$80.4K | ﹤0.01% | 2629 |
|
|
2023
Q4 | $113K | Buy |
+71,300
| New | +$113K | ﹤0.01% | 2928 |
|
|
2023
Q1 | – | Sell |
-69,600
| Closed | -$120K | – | 3486 |
|
|
2022
Q4 | $120K | Buy |
+69,600
| New | +$120K | ﹤0.01% | 2891 |
|
|
2021
Q3 | – | Sell |
-195,157
| Closed | -$1.28M | – | 3575 |
|
|
2021
Q2 | $1.28M | Buy |
195,157
+86,308
| +79% | +$564K | ﹤0.01% | 2215 |
|
|
2021
Q1 | $850K | Buy |
108,849
+101,871
| +1,460% | +$796K | ﹤0.01% | 2014 |
|
|
2020
Q4 | $52K | Buy |
6,978
+4,883
| +233% | +$36.4K | ﹤0.01% | 3449 |
|
|
2020
Q3 | $14K | Sell |
2,095
-1,525
| -42% | -$10.2K | ﹤0.01% | 3564 |
|
|
2020
Q2 | $30K | Buy |
+3,620
| New | +$30K | ﹤0.01% | 3295 |
|
|
2020
Q1 | – | Sell |
-5,630
| Closed | -$47K | – | 3829 |
|
|
2019
Q4 | $47K | Buy |
5,630
+1,680
| +43% | +$14K | ﹤0.01% | 3340 |
|
|
2019
Q3 | $29K | Buy |
3,950
+235
| +6% | +$1.73K | ﹤0.01% | 3385 |
|
|
2019
Q2 | $42K | Buy |
+3,715
| New | +$42K | ﹤0.01% | 3320 |
|
|
2019
Q1 | – | Sell |
-853
| Closed | -$13K | – | 3937 |
|
|
2018
Q4 | $13K | Buy |
853
+546
| +178% | +$8.32K | ﹤0.01% | 3432 |
|
|
2018
Q3 | $6K | Sell |
307
-34,367
| -99% | -$672K | ﹤0.01% | 3734 |
|
|
2018
Q2 | $792K | Sell |
34,674
-8,239
| -19% | -$188K | ﹤0.01% | 1915 |
|
|
2018
Q1 | $1.22M | Buy |
42,913
+37,083
| +636% | +$1.06M | ﹤0.01% | 1694 |
|
|
2017
Q4 | $124K | Buy |
+5,830
| New | +$124K | ﹤0.01% | 2637 |
|